drugset / Trial / NCT00991861
Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to determine the efficacy, safety and tolerability of either a once or twice daily topical application of LAS41007 compared to a twice daily application of LAS106521 in the treatment of actinic keratosis.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclofenac | Other / unclassified | — | Topical |
| Comparator | LAS106521 | Unknown | — | Topical |